Appendix. Appendix TOAST Abstraction Manual. TOAST Medical Record Abstraction Manual

Size: px
Start display at page:

Download "Appendix. Appendix TOAST Abstraction Manual. TOAST Medical Record Abstraction Manual"

Transcription

1 Appendix Appendix TOAST Abstraction Manual TOAST Medical Record Abstraction Manual Section 1A. History/Emboli All noted historical information must occur prior to index stroke admission. If a diagnosis is found within the discharge summary, it must not have been diagnosed during the index admission. It is often best to consult the admission history and physical for complete past medical history rather than discharge summary. You may wish to circle (or otherwise denote) presence of all applicable conditions. If both high risk and medium risk sources occur, score the section as [1] high risk source for emboli. If multiple medium risk sources are present (but no high risk), the section is scored [2] medium risk source for emboli. If no high or medium risk sources are present, score the question [3] No source for emboli. Mechanical prosthetic heart valve: Record this if explicitly stated in history. May be alternatively described as Starr- Edwards valve (ball and cage device), Medtronic-Hall (single tilting disc valve) or St. Jude Medical model (bi-leaflet valve). Bioprosthetic valves (e.g. porcine) are not considered high risk (see below) so it is important to distinguish between the types of valve replacements when possible. If it is stated that the person has a valve replacement (or prosthetic valve) but this is not further described keep the following in mind: (1) All persons with a mechanical valve of any sort should be anticoagulated before admission (usually with coumadin). However, persons with bioprosthetic valves sometimes require anticoagulation. (2) Persons with mechanical valve may be described as having a clink or metallic heart sound on cardiac physical exam. (3) All mechanical heart valves should be visible on chest x-ray (or echo) and appropriately described. (4) If the type of valve remains ambiguous after the following consideration, consider it a bioprosthetic valve and score it under [2] Medium risk source for emboli. Atrial fibrillation: Score this response if the patient has a documented history of any episode of atrial fibrillation prior to admission. Score even if the patient is being treated with anticoagulation (e.g. coumadin), antiarrhythmics (e.g. digoxin, calcium channel blockers, beta-blockers), has a pacemaker, or has been successfully undergone cardioversion in the past. Do not score other forms of supraventricular tachycardia or conduction abnormalities (e.g. multifocal atrial tachycardia, Wolff-Parkinson-White syndrome) Sick-sinus syndrome: Score this response if patient has history of sick-sinus syndrome, even if being treated with anticoagulation, antiarrhythmics (e.g. digoxin, calcium channel blockers, beta-blockers), or pacemaker. Myocardial Infarction (MI) within 4 weeks: as stated. Dilated cardiomyopathy: as stated per history. Atrial myxoma: as described by studies prior to admission (usually echocardiogram) Infective endocarditis: Score this item if at any time in the patient s history they were diagnosed with infective endocarditis. Score even if adequately treated and even if valve replacement surgery was subsequently performed. Akinetic left ventricular segment: Score if any prior echocardiogram described complete lack of wall motion in any segment of the left ventricle Left ventricular thrombus: Score this item if at any time in the patient s history they were found to have a thrombus in the left ventricle. Score even if the patient has completed their recommended course of anticoagulation or if currently taking anticoagulants. Score even if echocardiogram on current admission fails to find thrombus. MI >4 weeks ago but <6 months ago: as stated. Congestive heart failure: Score if recorded in patient s history at any time. Score regardless of patient s current medication regimen or echocardiographic findings on present admission. Left ventricular aneurysm: as recorded in history. Atrial flutter: Score if this rhythm recorded at any time. Score even if the patient is being treated with anticoagulation (e.g. coumadin), antiarrhythmics (e.g. digoxin, calcium channel blockers, beta-blockers), has a pacemaker, or has been successfully undergone cardioversion in the past. Bioprosthetic heart valve: Score as recorded in patient s history. May be described as porcine graft, xenograft, pericardial valve, Carpentier-Edwards (porcine xenograft), Biocor, or Sorin Pericarbon. If the type of prosthetic valve is not described, see mechanical valve above. Do NOT score if patient has aortic allograft or pulmonary valve homograft (Ross procedure). Mitral stenosis without atrial fibrillation: as recorded in history. Mitral valve prolapse: as recorded in history. Mitral annular calcification: as recorded in history or prior echocardiograms. Atrial septal defect: as recorded in history. Do NOT record if patient has undergone surgical closure of defect. Patent foramen ovale: as recorded in history or prior echocardiograms. Interatrial septal aneurysm: as recorded in history or prior echocardiograms. Nonbacterial endocarditis: as recorded in history. This would include marantic or Libman-Sacks endocarditis. Section 1B. History/Large Vessel Disease All noted historical information must occur prior to index stroke admission. If a diagnosis is found within the discharge summary, it must not have been diagnosed during the index admission. It is often best to consult the admission history and physical for complete past medical history rather than discharge summary. This section refers only to diagnosis made by relevant extracranial studies (e.g. Doppler/duplex, MRA, CT angiogram or conventional angiogram). Data gleaned from physical exam (e.g. bruits) are not relevant. In order for the lesion to be scored, it should be both extracranial and appropriate: carotid lesions should be greater than 50% stenosis and ipsilateral to symptoms vertebral lesions are relevant only in cases of brainstem infarction Data are to primarily obtained directly from radiological reports. If these are not available, then review information from admission notes, progress notes, or discharge summaries. If there is a conflict, use the data from the official radiology report. If percent stenosis is not given, translate keywords as follows: mild 16 49%, moderate 50 69%, severe 70 89%, critical 90 99%, and occluded 100%. Do not score a lesion as present if the lesion was documented only prior to corrective surgery (e.g. carotid endarterectomy). Studies performed at an outside hospital prior to transfer are considered to occur prior to admission and may be recorded in this section.

2 1092 Stroke May 2001 Section 1C. History/Prior Specialized Tests This section records any historical mention of conditions which are not related to large vessel atherosclerosis, cardiogenic embolism, or lipohyalinosis (small vessel disease) and, in view of a negative evaluation for these causes, have been indicated as the likely cause of the patient s stroke. If any of the diagnoses listed below are recorded in the past medical history, you can assume that the appropriate lab test has been conducted and score [1] Prior specialized tests (hematological, CSF, or histology) demonstrating evidence of underlying cause. The response [2] Negative prior specialized tests should be scored if any one or more tests listed below were previously conducted and ALL were found to be negative. If none of the specified diagnoses are carried or no specialized tests were performed, record [3] No prior specialized tests completed. The test/condition should be recorded on the form if present. Below follows a list of conditions known to be associated with stroke and the appropriate methods of diagnosis: Infectious vasculopathy: Neurosyphilis Neurotuberculosis Typhus Schistosomiasis Trichinosis Mycoses Mucormycoses Rickettsioses (e.g. Rocky Mountain Spotted Fever) Neuroborreliosis (Lyme disease) Neurobrucellosis Malaria HIV Herpes encephalitis Inflammatory vasculopathy: Systemic lupus erythematosus Scleroderma Sjogen s syndrome Polyarteritis nodosa Rheumatoid arthritis Takayasu s disease Wegener s granulomatosus Granulomatous angiitis of the CNS Degos-Kohlmeier Disease Churg-Strauss syndrome Behcet s syndrome Hodgkin s lymphoma Neurosarcoidosis Eale s disease Relapsing polychondritis Drug induced vasculitis Vasospasm Drug induced (amphetamine, cocaine, heroin, LSD, PCP, ecstasy) Congenital connective tissue disorders Marfan s syndrome Ehler s-danlos syndrome CSF: pleocytosis, high protein; VDRL>1 16; PCR; serum VDRL, RPR, or FTA-ABS CSF: pleocytosis, high protein, low glucose, AFB; PCR; MRI; PPD, chest x-ray, serology, PCR Microscopic urinalysis, stool for O& P Muscle biopsy, serology Specimen isolated in tissue Specimen isolated in tissue, serology, serology (ELISA) CSF: culture for brucella, IgG agglutination>1/160 Peripheral blood smear demonstrating vasculitis; serology, Western blot, PCR or AIDS defining illness CSF:PCR, brain biopsy, fana test, histology Lip biopsy, anti SSA and SSB antibodies Angiography, histology features, rheumatoid factor, canca Angiography, histology, gastroduodenal endoscopy Eosinophilia, histology, histology (nonspecific lab tests, e.g. ESR, are often abnormal) Urine and serum drug screens (there are specific tests for certain subtypes, such as protein electrophoresis (I,II), urine lysyl hydroxylase (VI), skin biopsy (IV, VIIb, VIIc), histology (skin) Pseudoxanthoma elasticum Fabry s Disease Functional assay for alpha-galactosidase A. Osler Weber Rendu Syndrome

3 Goldstein et al Improving the Reliability of Stroke Subgroup Classification 1093 Other non-inflammatory vasculopathies Fibromuscular dysplasia Moya moya Homocysteinemia Post-irradiation vasculopathy Neoplastic angioendotheliosis Dolichoectasia Amyloid angiopathy Sneddon s syndrome Spontaneous arterial dissection Venous sinus thrombosis Hematologic Severe Anemia Thrombotic thrombocytopenic purpura (TTP) Lupus anticoagulant Anticardiolipin antibody Sickle cell disease Thalassemias Hemoglobin SC disease Polycythemia rubra vera Waldenstrom s macroglobulinemia Cryoglobulinemia Essential thrombocythemia Myeloproliferative disorders Coagulation factor deficiencies: antithrombin III, protein C, protein S, plasminogen, factor VIII (hemophilia), factor XII, C2, prekallikrein, heparin cofactor II) Activated protein C resistance (e.g. Factor V Leiden) Platelet hyperaggregability Disseminated intravascular coagulation Vitamin K therapy Paroxysmal nocturnal hemoglobinuria Paraneoplastic syndrome Oral contraceptive induced hypercoagulability MELAS CADASIL Angiography Angiography Urine and serum homocysteine History, CT/MRI/Angiography/ Angiography, CT, MRI Angiography CT, MRI, angiography Complete blood count, Hemoglobin>7 g/dl features, peripheral blood smear (schistocytes) Functional assay for lupus anticoagulant ELISA for anticardiolipin antibody Hemoglobin electrophoresis Peripheral blood smear Hemoglobin electrophoresis Complete blood count, Hemoglobin>20 g/dl or requiring phlebotomy Serum and urine protein electrophoresis (SPEP and UPEP) SPEP Complete blood count, >600,000 platelets/mm3 Complete blood count, blood smear, bone marrow biopsy Serum factor levels by functional assay PCR for Factor V or functional assay for APC-R Platelet aggregation studies DIC panel, PT Ham test, flow cytometry Neoplasm, laboratory evidence of coagulopathy History/, laboratory evidence of hypercoagulable state, mitochondrial DNA analysis PCR for CADASIL gene

4 1094 Stroke May 2001 Section 2. Physical Exam Only physical exam findings obtained the day of admission are relevant. If there is no exam recorded upon the day of admission, use the exam closest to that date. Note that many discharge summaries are from rehabilitation units and may contain physical exam findings obtained at transfer therefore, it is best as a general rule to use admit day notes. Specific findings Atrial fibrillation: Under the cardiac exam, the phrase irregularly irregular shall be taken to be indicative of atrial fibrillation. This item may be scored if ANY examiner records the phrase irregularly irregular. Terms such as frequent ectopy, and descriptions of murmurs or extra heart sounds are not relevant. Tachycardia need not be present. EKG findings are NOT considered under this section. Evidence of systemic embolization: These would include visible clots on funduscopic exam, splinter hemorrhages, Roth spots, Janeway lesions, Osler s nodes. Classic lacunar syndromes: Note: this section relies heavily on an experienced physician s neurological examination. Therefore, in cases where physical exam findings differ, use the most experienced examiner. Neurologist s exams should be used in preference to that of emergency department physicians or internists wherever possible. The impression or assessment of the examining physician need not be explicitly stated as lacunar infarct but often is. The term small vessel distribution stroke is also frequently used. Lacunar syndromes can immediately be ruled out if any of the following are new findings: Alteration in consciousness (somnolence, coma) Aphasia Visual or visuospatial abnormalities Oculomotor abnormalities Disorders of higher mental function, including calculation, reading, writing recognition, attention, praxis Pure motor (hemiparesis/hemiplegia): New onset weakness of the face, arm and leg. All should be involved on the same side of the body, usually but not always to the same degree. Dysarthria is frequently present. Sensory findings and poor coordination inappropriate for muscle weakness should not be present. Pure Sensory: New onset sensory findings occurring on one side of the body, involving at least two of our three body areas (face, arm, leg). Objective findings of sensory loss are not required sensory symptoms (e.g. numbness) in the above noted distributions qualify. Motor and cerebellar findings should be absent. Mixed sensorimotor: Motor and sensory findings simultaneously located in at least 2 out of 3 body areas (face, arm and leg). Tongue deviation and dysarthria may be present. Ataxic Hemiparesis: Ipsilateral cerebellar ataxia and hemiparesis. Gait ataxia may be present, and the presence or absence of sensory findings on the same side of the body is variable. The face need not be involved, and arm and leg may be weak to varying extents. Dysarthria-Clumsy hand: Severe dysarthria, clumsy ataxic hand (especially on writing); facial weakness; tongue deviation may or may not be present, as may ipsilateral hyper-reflexia and Babinski sign. Section 3. Diagnostic Tests (A) CT Scan The TOAST algorithm is for cerebral infarction only. Any patient whose CT is read by radiology as having any of the following in absence of a clinically appropriate new infarct should be excluded from analysis: primary intracerebral hematoma (hemorrhage), intraparenchymal hemorrhage, intraventricular hemorrhage, subarachnoid hemorrhage, subdural hematoma, epidural hematoma, or any nonvascular lesion (e.g. neoplasm, intraparenchymal infection (e.g. toxoplasmosis)). Hemorrhagic infarction is not excluded from analysis (note: a hemorrhagic infarction is a hemorrhage originating within and secondary to infarction and has a characteristic radiographic appearance that distinguishes it from primary hemorrhage the distinction should be made on the radiographic report). Inasmuch as CT is relatively insensitive for ischemic infarct in the hyperacute stage (6 hr post ictus), readings from the acute stage (1 7 days post ictus) are preferred record data from scans done this period unless it is clinically evident that the patient has had a second event since admission. Data are primarily obtained from official radiology reports. Only in cases where these are not available should information be used from progress notes or the discharge. If there is conflict between the radiologist s interpretation and that of any other physician, the radiologist s opinion is considered authoritative for data collection purposes. If a patient is a transfer from an outside hospital and has imaging done only at the outside institution, this data may be recorded for this section (even if the scan is negative). If more than one CT scan is performed, use the results from the latest scan performed during the admission unless there was an interval change (i.e., clinically neurological significant change) in the patient s clinical status. If an interval change occurred, use the results from the earlier scan. For this section, only a single response is appropriate. Responses [1] [5] refer to acute infarcts only. Only score responses [8], [9], and [10] if responses [1] [7] are not applicable. Specific findings [1] Acute or subacute bland or hemorrhagic infarction involving cortical and possibly extending into subcortical structures, or infarct>1.5 cm in subcortical structures in the cerebral hemisphere, appropriate for symptoms, or multiple acute or subacute infarctions of same age in same vascular territory: The lesion should be described as a SINGLE bland (ischemic) or hemorrhagic infarct or as multiple recent infarcts (acute/subacute) in the vascular distribution of a single large extracranial artery. That is, multiple anterior circulation lesions should all occur in the same hemisphere, and brainstem lesions should not coexist with hemispheric lesions in the distribution of the ACA or MCA. PCA distribution infarcts may coexist with either anterior or posterior circulation infarcts or may involve both hemispheres. Cortical structures refers to the gray matter on the exterior of the cerebral hemispheres. Subcortical refers to deeper structures, including corona radiata, basal ganglia, internal capsule, thalamus. Progress notes should verify the concordances of any described lesions and the patient s clinical picture. Do not record any lesion here that is not clinically appropriate. [2] Acute or subacute infarct in the distribution of a circumferential artery in the brainstem and/or cerebellum: Typically 1.5 cm (non-lacunar) infarcts in the distribution of any one of the circumferential arteries of the brainstem/ cerebellum. Long circumferential vessels include posterior inferior cerebellar (PICA), anterior inferior cerebellar (AICA), superior cerebellar (SCA), and the proximal portion of the posterior cerebral artery. There are numerous short circumferential vessels that arise from the basilar artery also. Score this only if a SINGLE new lesion is present. [3] Multiple acute or subacute infarctions of same age in different vascular territories: Score this response if there are multiple non-lacunar acute or subacute infarcts of the same age occurring in the distribution of more than one large extracranial artery (carotid or vertebral artery). This would include any anterior circulation (ACA, MCA) infarct coexisting with a brainstem or contralateral hemisphere infarct. [4] Hyper-dense artery sign: Score this response if a hyperdense artery sign is specifically described in the radiology report in the presumed distribution of the infarct. Do not score

5 Goldstein et al Improving the Reliability of Stroke Subgroup Classification 1095 if items [1], [2], [3], or [5] are applicable score them instead. [5] <1.5 cm in diameter infarct in a subcortical structure or brainstem in the territory of a small penetrating artery: Infarct should be smaller than 1.5 cm (or described as small or lacunar ). Typical subcortical locations include corona radiata, internal capsule, external capsule, basal ganglia, thalamus. Lesions may also be located in the pons or medulla. You may score this response if ANY one of multiple new lacunar infarcts is appropriate for symptoms. You may also score this response if there is a clinically appropriate lesion of undetermined age. Do not score if the patient is described as having Binswanger s disease (encephalopathy) unless there is a discrete new lesion appropriate for symptoms. [6] Normal: Score this response if the scan is read as normal or age appropriate atrophy or if the radiology report is unavailable and progress notes or discharge summary records indicate as normal, unremarkable, without change, et cetera. [7] Not Done: Score if no CT was performed, if no data regarding the CT can be found, or if the scan was non-diagnostic (e.g. poor quality or uninterpretable). [8] Old stroke, same vascular territory: Score this response only if: [1] [7] are not applicable and the scan shows an old infarct in the same vascular distribution as the new lesion. If the location of the present lesion is unclear and the CT shows only an old infarct, score [9]. If there are multiple old strokes in more than one vascular territory (e.g. bilateral infarcts) then score [9]. [9] Old stroke, different vascular territory: Score this response only if: [1] [7] are not applicable and the scan shows an old infarct in a different vascular distribution as the new lesion OR if the location of the present lesion is unclear and the CT shows only an old infarct OR if there are multiple old strokes in more than one vascular territory. [10] Old, nonspecific small vessel disease: Score this response only if: [1] [9] are not applicable and the scan shows patchy, white matter periventricular disease. Lacunar infarct(s) may be present. Score this also if the terms Binswanger s disease (encephalopathy) or leukoencephalopathy are used. (B) MRI The TOAST algorithm is for cerebral infarction only. Any patient whose MRI is read as having hemorrhage or nonvascular lesions (see CT section for examples) in the absence of an infarct that accounts for new clinical findings should be excluded. MRI findings for ischemic infarct in the hyper-acute stage (24 hr) can be subtle therefore if multiple scans are done, use readings from the acute stage (1 7 days post ictus) unless it is clinically evident that the patient has had a second event since admission. In such a case, use the latest MRI scan occurring before the event. If a patient is a transfer from an outside hospital and has imaging done only at the outside institution, this data may be recorded for this section (even if the scan is negative). Data are primarily obtained from official radiology reports. Only in cases where these are not available should information found in progress notes or the discharge summary be used. If there is conflict between the radiologist s interpretation and that of any other physician, the radiologist s opinion is considered authoritative for data collection purposes. If more than one MRI scan is performed, use the results from the latest scan performed during the admission unless there was an interval change (i.e., clinically neurologically significant change) in the patient s clinical status. If an interval change occurred, use the results from the earlier scan. For this section, only a single response is appropriate. Responses [1] [5] refer to acute infarcts only. Only score responses [8], [9], and [10] if responses [1] [7] are not applicable. Specific findings [1] Acute or subacute bland or hemorrhagic infarction involving cortical structures and possibly extending into subcortical structures, or infarct>1.5 cm in subcortical structures in the cerebral hemisphere, appropriate for symptoms, or multiple acute or subacute infarctions of same age in same vascular territory: The lesion should be described as a SINGLE bland (ischemic) or hemorrhagic infarct or as multiple recent infarcts (acute/subacute) in the vascular distribution of a single large extracranial artery. That is, multiple anterior circulation lesions should all occur in the same hemisphere, and brainstem lesions should not coexist with hemispheric lesions in the distribution of the ACA or MCA. PCA distribution infarcts may coexist with either anterior or posterior circulation infarcts or may involve both hemispheres. Cortical structures refers to the gray matter on the exterior of the cerebral hemispheres. Subcortical refers to deeper structures, including corona radiata, basal ganglia, internal capsule, thalamus. Progress notes should verify the concordances of any described lesions and the patient s clinical picture. Do not record any lesion here that is not clinically appropriate. [2] Acute or subacute infarct in the distribution of a circumferential artery in the brainstem and/or cerebellum: Typically 1.5 cm (non-lacunar) infarcts in the distribution of any one of the circumferential arteries of the brainstem/ cerebellum. Long circumferential vessels include posterior inferior cerebellar (PICA), anterior inferior cerebellar (AICA), superior cerebellar (SCA), and the proximal portion of the posterior cerebral artery. There are numerous short circumferential vessels that arise from the basilar artery also. Score this only if a SINGLE new lesion is present. [3] Multiple acute or subacute infarctions of same age in different vascular territories: Score this response if there are multiple non-lacunar acute or subacute infarcts of the same age occurring in the distribution of more than one large extracranial artery (carotids or vertebral arteries). This would include any anterior circulation (ACA, MCA) infarct coexisting with a brainstem or contralateral hemisphere infarct. [4] Absence of a flow void in major extracranial artery: Score this response if the radiology report records an absence flow void in a clinically appropriate major extracranial vessel (extracranial carotid or vertebral arteries). Do not score if items [1], [2], [3], or [5] are applicable score them instead. [5] <1.5 cm in diameter infarct in a subcortical structure or brainstem in the territory of a small penetrating artery: Infarct should be smaller than 1.5 cm (or described as small or lacunar ). Typical subcortical locations include corona radiata, internal capsule, external capsule, basal ganglia, thalamus. Lesions may also be located in the pons or medulla. You may score this response if ANY one of multiple new lacunar infarcts is appropriate for symptoms. You may also score this response if there is a clinically appropriate lesion of undetermined age. Do not score if the patient is described as having Binswanger s disease (encephalopathy) unless there is a discrete new lesion appropriate for symptoms. [6] Normal: Score this response if the scan is read as normal, or age appropriate atrophy or if the radiology report is unavailable and progress notes or discharge summary records as normal, unremarkable, without change, et cetera. [7] Not Done: Score if no MRI was performed, if no data regarding the MRI can be found, or if the scan was non-diagnostic (e.g. poor quality or un-interpretable). [8] Old stroke, same vascular territory: Score this response only if: [1] [7] are not applicable and the scan shows an old infarct in the same vascular distribution as the new lesion. If the location of the present lesion is unclear and the MRI shows only an old infarct, score [9]. If there are multiple old strokes in more than one vascular territory (e.g.

6 1096 Stroke May 2001 bilateral infarcts) then score [9]. [9] Old stroke, different vascular territory: Score this response only if: [1] [7] are not applicable and the scan shows an old infarct in a different vascular distribution as the new lesion OR if the location of the present lesion is unclear and the MRI shows only an old infarct OR if there are multiple old strokes in more than one vascular territory. [10] Old, nonspecific small vessel disease: Score this response only if: [1] [9] are not applicable and the scan shows patchy, white matter periventricular disease. Lacunar infarct(s) may be present. Score this also if the terms Binswanger s disease (encephalopathy) or leukoencephalopathy are used. (C) Non-invasive vascular studies Official radiology reports should be considered the primary source for data collection if the final report is not available, the preliminary report may be used. Only in cases where these are not available should information found in progress notes or the discharge summary be used. If there is conflict between the radiologist s interpretation and that of any other physician, the radiologist s opinion is considered authoritative for data collection purposes. Check the appropriate box describing the study performed. If both studies were performed and data is available, check [] MRA and evaluate MRA results only. If both studies were done but interpretable data is available for only one, check that box and evaluate the study below. If neither study was performed or data are unavailable, check [3] Not Done. Specific responses [1] Greater than or equal to 50% stenosis of an appropriate large extracranial artery: Stenosis should be greater or equal to 50% or described as mild-moderate, moderate, severe or critical. The lesion should be in the extracranial carotid artery ipsilateral to the lesion (for hemispheric lesions) or in either vertebral artery for posterior circulation lesions. Do not score lesions in the MCA artery, carotid siphon, basilar artery, or circle of Willis. [2] Less than 50% stenosis of an appropriate large extracranial artery: Stenosis should be less than 50% or described as absent, mild, or not hemodynamically significant. If there is a percentage estimate of stenosis record data according to this rather than key words/descriptors. Data should be collected on the appropriate artery only (ipsilateral carotid artery for hemispheric disease, vertebral arteries for posterior circulation disease). [3] Not Done: Score this response if there is no interpretable data from either study (either not done or poor quality). (D) Cerebral arteriogram Official radiology reports should be considered the primary source for data collection if the final report is not available, the preliminary report may be used. Only in cases where these are not available should information found in progress notes or the discharge summary be used. If there is conflict between the radiologist s interpretation and that of any other physician, the radiologist s opinion is considered authoritative for data collection purposes. A single response is expected for this question. If response [4] is appropriate, score this instead of any other finding that may be present. Specific responses [1] Occlusion, greater than or equal to 50% stenosis or greater than or equal to 2 mm ulceration of an appropriate large extracranial or intracranial artery: Stenosis should be greater or equal to 50% or described as mild-moderate, moderate, severe, critical or completely occluded. Alternatively, an ulcerated plaque greater than or equal to 2 mm can be present. For hemispheric lesions, the ipsilateral common carotid, internal carotid, middle cerebral, anterior cerebral, circle of Willis, or posterior cerebral may be scored. For brainstem lesions, consider lesions in the vertebral arteries, basilar artery, or any long circumferential artery (PICA, AICA, SCA). Do not consider lesions in smaller arteries or lesions in the aortic arch or subclavian arteries. [2] Less than 50% stenosis or less than 2 mm ulceration of an appropriate large extracranial or intracranial artery, with no occlusion of appropriate stem, division, or branch artery: Stenosis in all appropriate arteries should be less than 50% or described as absent, mild, or not hemodynamically significant. If there is a percentage estimate of stenosis record data according to this rather than key words/descriptors. [3] Less than 50% stenosis or less than 2 mm ulceration of an appropriate large extracranial or intracranial artery, with occlusion of appropriate stem, division, or branch artery: Stenosis in the appropriate arteries should be less than 50% or described as absent, mild, or not hemodynamically significant. There should be reported occlusion of a stem, division, or branch artery (any artery derived from the larger ones mentioned in [1]). [4] Specific, non-atherosclerotic, intra- or extra-cranial vascular pathology: Score this if findings are present indicating a specific form of vascular pathology not related to atherosclerosis (such as is mentioned in section 1C). The lesions do not necessarily have to be in the distribution of the infarct. Do not score this section to indicate small vessel disease or non-significant atherosclerotic disease. [5] Normal: Score this if no pathology is found on the arteriogram. [6] Not done: Score this if the study was not performed, if data is not available, or if the study was uninterpretable. (E) Cardiovascular Evaluation This section is scored by compiling data from individual cardiovascular system tests, specifically (a) echocardiogram, (b) EKG, and (c) Holter monitor/telemetry. [1] High-risk source for emboli: should be scored if ANY of the three cardiovascular subsections has a [1] high risk source for emboli. [2] Medium risk source for emboli: should be scored if ANY section has a [2] medium risk source for emboli and NO section has a [1] high risk source for emboli. [3] No high or medium risk source for emboli: should be scored if [3] (Nonspecific abnormalities or) Normal is scored for the echocardiogram section and the EKG section and the Holter monitor is either [3] Normal or [4] Not done. This section should also be scored if the echocardiogram is normal, Holter monitor is normal, and EKG is normal or not done. [4] Incomplete evaluation or evaluation not done: Score if echocardiogram is [4] Not done and EKG and Holter monitor are either [3] normal or [4] not done. Specific cardiovascular tests Echocardiogram Mark the appropriate box describing the test done. If both transesophageal (TEE) and transthoracic echocardiograms (TTE) are performed, mark [] TEE and evaluate data ONLY from the TEE. If it is not specified which type of study was performed, mark [] TTE. If no echocardiogram was performed (or the study was completely uninterpretable) mark [4] Not done. Use data from the official report when present. If it is not present, use data from progress notes or discharge summary. You may wish to circle arrows (or otherwise denote) presence of all applicable conditions. However, if both high risk and medium risk sources occur, score the section as [1] high risk source for emboli. If multiple medium risk sources are present (but no high risk), the section is scored [2] medium risk source for emboli. If no high or medium risk sources are present, score the section as [3] Normal.

7 Goldstein et al Improving the Reliability of Stroke Subgroup Classification 1097 Left ventricular thrombus: Circle this response if notation of a thrombus (or thrombi) anywhere within the left ventricle is described (e.g. mural, apical), regardless of whether the patient is or was taking anticoagulants. Dilated Cardiomyopathy: As stated per report, or if there is the combination of impaired systolic function (EF 45%), dilation of one or both ventricles, and symptoms of congestive heart failure. Akinetic left ventricular segment: As stated per report. Do NOT consider hypokinetic or dyskinetic segments to be akinetic. Left atrial thrombus: Circle this response if notation of a thrombus (or thrombi) anywhere within the left atrium is described regardless of whether the patient is or was taking anticoagulants. Atrial myxoma: As stated per report. Infective endocarditis: As stated per report, or if valvular vegetations occur in the setting of febrile illness. Congestive heart failure (CHF): As stated, or impaired systolic function (EF 45%) accompanied by classic physical findings (pedal edema, pulmonary edema, orthopnea, paroxysmal nocturnal dyspnea, hepatolmegaly, S3, S4) WITHOUT dilation of ventricles. If the ventricles are dilated, circle Dilated cardiomyopathy, and score the section as [1] High risk source for emboli even if discharge diagnosis is congestive heart failure. Left ventricular aneurysm: As stated, or if any wall of the left ventricle is stated to be dyskinetic. Aortic stenosis without atrial fibrillation: As stated. Do NOT score aortic sclerosis or calcific aortic sclerosis. Mitral valve prolapse: Score only if specifically diagnosed by echocardiogram. Mitral regurgitation need not be present. Mitral annular calcification: As stated. Atrial septal defect: As stated, or if any of the following terms are used: ostium primum defect, foramen primum defect, ostium secundum defect, or foramen primum defect. Do not circle for patent foramen ovale or atrioventricular canal. If there is an inter-atrial shunt as described by bubble study and no lesion is specified, you may score this response. Patent foramen ovale: As stated, regardless or presence, direction, or magnitude of inter-atrial shunt. Interatrial septal aneurysm: As stated. Nonbacterial endocarditis: As stated, regardless of location or size of vegetations. The terms marantic endocarditis or Libman-Sacks endocarditis may also be used and should be scored. Electrocardiogram (EKG)/Long rhythm strip Obtain information from original EKGs whenever possible. If more than one EKG is present in the chart, all should be evaluated and findings that occur on ANY EKG should be recorded. If no original EKG s are available, then interpretation found in the admission notes, progress notes or discharge summary may be used. If ANY EKG demonstrates a high-risk source for emboli, score the section [1] High risk source for emboli. If ANY EKG shows a medium risk source for emboli and NO EKG shows a high-risk source, the item should be scored [2] Medium risk source for emboli. If no high or medium risk sources for emboli are found on ANY EKG, then score [3] Nonspecific abnormalities or normal. If no EKG or report of EKG findings is found (or if all present studies are uninterpretable), then score the item [4] Not done. Atrial fibrillation demonstrated at any time during the hospitalization: As stated per interpretation, or all of the following: Absence of discrete P waves, fibrillating baseline, irregularly irregular narrow QRS complexes. Ventricular rate may be fast or slow. Score regardless of patient s current or past medication regimen. Acute myocardial infarction: As stated per report, or: an evolving pattern of EKG findings, culminating with the appearance of new Q waves in the appropriate leads. First T wave peaking occurs, then T wave inversion, then ST elevation, and finally new Q waves. New Q waves are diagnostic of infarction the other findings are merely suggestive and should not be scored without clinical correlation. Do NOT score infarct of indeterminate age. Atrial flutter demonstrated at any time during the hospitalization: As stated per interpretation, or all of the following: P wave at bpm, baseline with sawtooth pattern (flutter waves), regularly occurring QRS complexes in a given ratio with P waves. Holter monitor/telemetry Findings from either a Holter monitor or telemetry are appropriate for this section. If multiple tests were performed, then all should be evaluated and the highest risk source of emboli should be recorded. Obtain information from original tracings (or Holter monitor report) whenever possible. For telemetry, all tracings should be evaluated and findings that occur on tracing should be recorded. If no original tracings are available, then interpretation found in the progress notes or discharge summary may be used. If ANY tracing (or the Holter monitor report) demonstrates a high-risk source for emboli, score the section [1] High risk source for emboli. If ANY tracing shows a medium risk source for emboli and NO tracing shows a high risk source, the item should be scored [2] Medium risk source for emboli. If no high or medium risk sources for emboli are found on ANY tracing, then score [3] Nonspecific abnormalities or normal. If no tracing (or Holter monitor report) or report of tracing (or monitor) findings is found (or if all present studies are uninterpretable), then score the item [4] Not Done. Atrial fibrillation demonstrated at any time during hospitalization: As stated per interpretation, or all of the following: Absence of discrete P waves, fibrillating baseline, irregularly irregular narrow QRS complexes. Ventricular rate may be fast or slow. Score regardless of patient s current or past medication regimen. Sick sinus syndrome: As stated per report, or: the term tachy-brady syndrome is used, or if there are alternating bouts of supraventricular tachycardia (e.g. atrial flutter) and bradycardia. You should score this if it is present regardless of medication regimen or pacemaker placement. Atrial flutter demonstrated at any time during hospitalization: As stated per interpretation, or all of the following: P wave at bpm, baseline with sawtooth pattern (flutter waves), regularly occurring QRS complexes in a fixed ratio with P waves. (F) Specialized tests (hematological, CSF, or histology) This section records data derived from any specific tests performed to evaluate for presence of diseases which increase the likelihood of stroke by means of a mechanism which is not related to large vessel atherosclerosis, cardiogenic embolism, or lipohyalinosis. A comprehensive list of such diagnoses and the appropriate tests or diagnostic criteria are listed in section 1C (History, prior specialized tests). If any of the tests mentioned in section 1C were performed and found to demonstrate evidence of the accepted other etiologies of cerebral infarct, score: [1] Complete set of studies demonstrating evidence of underlying cause if one or more of the bold faced tests was performed and found to be positive or [2] Incomplete set of studies demonstrating evidence of underlying cause if only non-bold faced tests were performed and found to be positive or [3] Normal if non-bold tests were positive but any boldfaced test was negative. The response [3] Normal should be scored if any one or more tests listed was conducted for the purposes of evaluating for other etiologies and ALL were found to be negative. If no specialized tests were performed, record [4] Incomplete or not done.

8 1098 Stroke May 2001 Section 4. Postmortem Examination Any postmortem examination is valid for evaluation, regardless of the recorded cause of death or time discrepancy between infarct and postmortem examination. The only exception would be any person who has had a second event (of any nature, including surgical) involving the brain tissue or vasculature which was implicated in the index infarct. Pathological findings should only be recorded as they are relevant to tissue and vasculature involved in the index infarct. If no infarct was detected by imaging, the infarct found during autopsy should correspond to the clinical findings. [1] Bland or hemorrhagic infarct, an atheromatous lesion (possibly with adherent thrombus) of an appropriate, large extracranial artery or possibly occlusion of superficial or cortical arteries: A bland or hemorrhagic infarct, involving cortical or subcortical structures, appropriate for clinical presentation and corresponding to radiographic findings (if present) should be described. Furthermore, significant atherosclerosis (greater than or equal to 50% stenosis) should be present in the appropriate large arteries supplying the territory of the infarct. There may or may not be atherosclerotic disease in the branch, stem, or division arteries supplying the territory of the infarct. Do not consider atherosclerosis in cerebral vessels not involved with the infarct or in any other systemic vessels. [2] Bland or hemorrhagic infarct(s), arterial occlusion by an embolus and underlying heart disease: Bland or hemorrhagic infarct(s) as mentioned above, with embolic arterial occlusion in a vessel supplying at least one of the lesions identified clinically or radiographically during the index admission. Do not consider any other embolic events. Underlying heart disease must also be present. The pathology report may describe any of the following: left ventricular thrombus, myocardial infarction less than 4 weeks old, dilated ventricles, atrial thrombus, atrial myxoma, infective endocarditis, aortic stenosis (not aortic sclerosis or bicuspid aortic valve), mitral stenosis, mitral annular calcification, myxomatous degeneration of the mitral valve, atrial septal defect (ostium primum or ostium secundum), patent foramen ovale (including probe patent ), nonbacterial endocarditis (marantic, Libman-Sacks), mechanical or bioprosthetic heart valve (not homograft). [3] Small deep infarct in the territory of a penetrating artery: Infarct less than 1.5 cm in diameter in a deep structure (corona radiata, internal capsule, external capsule, basal ganglia, thalamus, pons, or medulla). Score even if an embolus is present within the small artery supplying the region of infarct. Do not score if there is evidence of arterial occlusion of other etiology (e.g. vasculitis, hematological abnormality, etc). [4] Bland or hemorrhagic infarct, without significant atherosclerosis, normal cardiac pathology, and arterial occlusion of specific etiology: Infarct of ANY size or location corresponding clinically and radiologically to the infarct described in the index admission accompanied by: (1) lack of significant atherosclerosis involving vessels supplying the infarct, (2) lack of embolic occlusion of the relevant vessel(s), (3) lack of cardiac pathology suggestive of embolism (see [2]), and (4) evidence of a specific disease state predisposing to cerebral infarction. Specific disease states, which meet criterion (4), are listed in section 1C History/ Prior Specialized Tests. [5] Infarction but no specific vascular pathology: Score this response if the pathology report documents: (1) lack of significant atherosclerosis involving vessels supplying the infarct, (2) lack of embolic occlusion of the relevant vessel(s), (3) lack of cardiac pathology suggestive of embolism (see [2]), and (4) no evidence of a specific disease state predisposing to cerebral infarction. Subclinical atherosclerosis would fall into this category. [6] Not done: Score this response if (1) no postmortem examination was performed, (2) an incomplete postmortem examination was performed (e.g., no brain or heart pathological examination), or (3) data from the autopsy is unavailable.

[(PHY-3a) Initials of MD reviewing films] [(PHY-3b) Initials of 2 nd opinion MD]

[(PHY-3a) Initials of MD reviewing films] [(PHY-3b) Initials of 2 nd opinion MD] 2015 PHYSICIAN SIGN-OFF (1) STUDY NO (PHY-1) CASE, PER PHYSICIAN REVIEW 1=yes 2=no [strictly meets case definition] (PHY-1a) CASE, IN PHYSICIAN S OPINION 1=yes 2=no (PHY-2) (PHY-3) [based on all available

More information

/ / / / / / Hospital Abstraction: Stroke/TIA. Participant ID: Hospital Code: Multi-Ethnic Study of Atherosclerosis

/ / / / / / Hospital Abstraction: Stroke/TIA. Participant ID: Hospital Code: Multi-Ethnic Study of Atherosclerosis Multi-Ethnic Study of Atherosclerosis Participant ID: Hospital Code: Hospital Abstraction: Stroke/TIA History and Hospital Record 1. Was the participant hospitalized as an immediate consequence of this

More information

DIFFERENT STROKES FOR DIFFERENT FOLKS!!

DIFFERENT STROKES FOR DIFFERENT FOLKS!! DIFFERENT STROKES FOR DIFFERENT FOLKS!! Identifying Stroke Subtypes SWAROOP PAWAR M.D., MPH. Vascular Neurologist UMG Neuroscience Associates Greenville Health System None Disclosures Outline Stroke, TIA

More information

MD SUBTYPE ADJUDICATION VARIABLE DEFINITIONS MANUAL The following is a list of variables and how to complete each one:

MD SUBTYPE ADJUDICATION VARIABLE DEFINITIONS MANUAL The following is a list of variables and how to complete each one: MD SUBTYPE ADJUDICATION VARIABLE DEFINITIONS MANUAL 2014-15 The following is a list of variables and how to complete each one: (PHY-1) Case, per physician review: The most important task for the physicians

More information

CEREBRO VASCULAR ACCIDENTS

CEREBRO VASCULAR ACCIDENTS CEREBRO VASCULAR S MICHAEL OPONG-KUSI, DO MBA MORTON CLINIC, TULSA, OK, USA 8/9/2012 1 Cerebrovascular Accident Third Leading cause of deaths (USA) 750,000 strokes in USA per year. 150,000 deaths in USA

More information

Essentials of Clinical MR, 2 nd edition. 14. Ischemia and Infarction II

Essentials of Clinical MR, 2 nd edition. 14. Ischemia and Infarction II 14. Ischemia and Infarction II Lacunar infarcts are small deep parenchymal lesions involving the basal ganglia, internal capsule, thalamus, and brainstem. The vascular supply of these areas includes the

More information

CLINICAL FEATURES THAT SUPPORT ATHEROSCLEROTIC STROKE 1. cerebral cortical impairment (aphasia, neglect, restricted motor involvement, etc.) or brain stem or cerebellar dysfunction 2. lacunar clinical

More information

What is the appropriate evaluation of cryptogenic stroke, and when is a hypercoagulability work-up needed? David E. Thaler, MD, PhD, FAHA

What is the appropriate evaluation of cryptogenic stroke, and when is a hypercoagulability work-up needed? David E. Thaler, MD, PhD, FAHA What is the appropriate evaluation of cryptogenic stroke, and when is a hypercoagulability work-up needed? David E. Thaler, MD, PhD, FAHA Neurologist in Chief, Tufts Medical Center Professor and Chair

More information

Stroke School for Internists Part 1

Stroke School for Internists Part 1 Stroke School for Internists Part 1 November 4, 2017 Dr. Albert Jin Dr. Gurpreet Jaswal Disclosures I receive a stipend for my role as Medical Director of the Stroke Network of SEO I have no commercial

More information

Neuropathology lecture series. III. Neuropathology of Cerebrovascular Disease. Physiology of cerebral blood flow

Neuropathology lecture series. III. Neuropathology of Cerebrovascular Disease. Physiology of cerebral blood flow Neuropathology lecture series III. Neuropathology of Cerebrovascular Disease Physiology of cerebral blood flow Brain makes up only 2% of body weight Percentage of cardiac output: 15-20% Percentage of O

More information

Brain Attack. Strategies in the Management of Acute Ischemic Stroke: Neuroscience Clerkship. Case Medical Center

Brain Attack. Strategies in the Management of Acute Ischemic Stroke: Neuroscience Clerkship. Case Medical Center Brain Attack Strategies in the Management of Acute Ischemic Stroke: Neuroscience Clerkship Stroke is a common and devastating disorder Third leading antecedent of death in American men, and second among

More information

CVA. Alison Atwater PA-C

CVA. Alison Atwater PA-C CVA Alison Atwater PA-C Types of CVAs Ischemic strokes 80% of strokes 2/3 are thrombotic 1/3 are embolic emboli from the heart or arteries feeding the brain such as carotids, vertebral and basilar etc

More information

ACUTE CENTRAL PERIFERALEMBOLISM

ACUTE CENTRAL PERIFERALEMBOLISM EAE TEACHING COURSE 2010 Belgrade, Serbia October 22-23, 2010 ACUTE CENTRAL and PERIFERALEMBOLISM Maria João Andrade Lisbon, PT BACKGROUND Stroke is a leading cause of mortality and long-term disability

More information

CMS Limitations Guide - Radiology Services

CMS Limitations Guide - Radiology Services CMS Limitations Guide - Radiology Services Starting October 1, 2015, CMS will update their existing medical necessity limitations on tests and procedures to correspond to ICD-10 codes. This limitations

More information

How to Evaluate Patients with Cryptogenic Stroke

How to Evaluate Patients with Cryptogenic Stroke How to Evaluate Patients with Cryptogenic Stroke Jeffrey Saver, MD Professor of Neurology Director, How to Evaluate Patients with Cryptogenic Stroke Disclosure Scientific Consultant, Unpaid Trialist: AGA

More information

Neuroanatomy of a Stroke. Joni Clark, MD Professor of Neurology Barrow Neurologic Institute

Neuroanatomy of a Stroke. Joni Clark, MD Professor of Neurology Barrow Neurologic Institute Neuroanatomy of a Stroke Joni Clark, MD Professor of Neurology Barrow Neurologic Institute No disclosures Stroke case presentations Review signs and symptoms Review pertinent exam findings Identify the

More information

Detailed Order Request Checklists for Cardiology

Detailed Order Request Checklists for Cardiology Next Generation Solutions Detailed Order Request Checklists for Cardiology 8600 West Bryn Mawr Avenue South Tower Suite 800 Chicago, IL 60631 www.aimspecialtyhealth.com Appropriate.Safe.Affordable 2018

More information

EAE RECOMMENDATIONS FOR TRANSESOPHAGEAL ECHO. Cardiac Sources of Embolism. Luigi P. Badano, MD, FESC

EAE RECOMMENDATIONS FOR TRANSESOPHAGEAL ECHO. Cardiac Sources of Embolism. Luigi P. Badano, MD, FESC EAE RECOMMENDATIONS FOR TRANSESOPHAGEAL ECHO. Cardiac Sources of Embolism Luigi P. Badano, MD, FESC Background Stroke is the 3 cause of death in several industrial countries; Embolism accounts for 15-30%

More information

Cerebrovascular Disease

Cerebrovascular Disease Neuropathology lecture series Cerebrovascular Disease Kurenai Tanji, M.D., Ph.D. December 11, 2007 Physiology of cerebral blood flow Brain makes up only 2% of body weight Percentage of cardiac output:

More information

Direct oral anticoagulants for Embolic Strokes of Undetermined Source? George Ntaios University of Thessaly, Larissa/Greece

Direct oral anticoagulants for Embolic Strokes of Undetermined Source? George Ntaios University of Thessaly, Larissa/Greece Direct oral anticoagulants for Embolic Strokes of Undetermined Source? George Ntaios University of Thessaly, Larissa/Greece Disclosures Scholarships: European Stroke Organization; Hellenic Society of Atherosclerosis.

More information

SUBSPECIALTY CERTIFICATION EXAMINATION IN VASCULAR NEUROLOGY Content Blueprint (December 8, 2017)

SUBSPECIALTY CERTIFICATION EXAMINATION IN VASCULAR NEUROLOGY Content Blueprint (December 8, 2017) SUBSPECIALTY CERTIFICATION EXAMINATION IN VASCULAR NEUROLOGY 2018 Content Blueprint (December 8, 2017) Number of questions: 200 questions Percent 01. Basic science aspects of vascular neurology 4-6% 02.

More information

(For items 1-12, each question specifies mark one or mark all that apply.)

(For items 1-12, each question specifies mark one or mark all that apply.) Form 121 - Report of Cardiovascular Outcome Ver. 9.2 COMMENTS -Affix label here- Member ID: - - To be completed by Physician Adjudicator Date Completed: - - (M/D/Y) Adjudicator Code: - Central Case No.:

More information

Cerebral Vascular Diseases. Nabila Hamdi MD, PhD

Cerebral Vascular Diseases. Nabila Hamdi MD, PhD Cerebral Vascular Diseases Nabila Hamdi MD, PhD Outline I. Stroke statistics II. Cerebral circulation III. Clinical symptoms of stroke IV. Pathogenesis of cerebral infarcts (Stroke) 1. Ischemic - Thrombotic

More information

Acute stroke. Ischaemic stroke. Characteristics. Temporal classification. Clinical features. Interpretation of Emergency Head CT

Acute stroke. Ischaemic stroke. Characteristics. Temporal classification. Clinical features. Interpretation of Emergency Head CT Ischaemic stroke Characteristics Stroke is the third most common cause of death in the UK, and the leading cause of disability. 80% of strokes are ischaemic Large vessel occlusive atheromatous disease

More information

Patent Foramen Ovale and Cryptogenic Stroke: Do We Finally Have Closure? Christopher Streib, MD, MS

Patent Foramen Ovale and Cryptogenic Stroke: Do We Finally Have Closure? Christopher Streib, MD, MS Patent Foramen Ovale and Cryptogenic Stroke: Do We Finally Have Closure? Christopher Streib, MD, MS 11-8-18 Outline 1. Background 2. Anatomy of patent foramen ovale (PFO) 3. Relationship between PFO and

More information

Overview of Stroke: Etiologies, Demographics, Syndromes, and Outcomes. Alex Abou-Chebl, MD, FSVIN Medical Director, Stroke Baptist Health Louisville

Overview of Stroke: Etiologies, Demographics, Syndromes, and Outcomes. Alex Abou-Chebl, MD, FSVIN Medical Director, Stroke Baptist Health Louisville Overview of Stroke: Etiologies, Demographics, Syndromes, and Outcomes Alex Abou-Chebl, MD, FSVIN Medical Director, Stroke Baptist Health Louisville Disclosure Statement of Financial Interest Within the

More information

Adult Echocardiography Examination Content Outline

Adult Echocardiography Examination Content Outline Adult Echocardiography Examination Content Outline (Outline Summary) # Domain Subdomain Percentage 1 2 3 4 5 Anatomy and Physiology Pathology Clinical Care and Safety Measurement Techniques, Maneuvers,

More information

Cerebrovascular Disease

Cerebrovascular Disease Neuropathology lecture series Cerebrovascular Disease Physiology of cerebral blood flow Brain makes up only 2% of body weight Percentage of cardiac output: 15-20% Percentage of O 2 consumption (resting):

More information

ARIC HEART FAILURE HOSPITAL RECORD ABSTRACTION FORM. General Instructions: ID NUMBER: FORM NAME: H F A DATE: 10/13/2017 VERSION: CONTACT YEAR NUMBER:

ARIC HEART FAILURE HOSPITAL RECORD ABSTRACTION FORM. General Instructions: ID NUMBER: FORM NAME: H F A DATE: 10/13/2017 VERSION: CONTACT YEAR NUMBER: ARIC HEART FAILURE HOSPITAL RECORD ABSTRACTION FORM General Instructions: The Heart Failure Hospital Record Abstraction Form is completed for all heart failure-eligible cohort hospitalizations. Refer to

More information

HEART AND SOUL STUDY OUTCOME EVENT - MORBIDITY REVIEW FORM

HEART AND SOUL STUDY OUTCOME EVENT - MORBIDITY REVIEW FORM REVIEW DATE REVIEWER'S ID HEART AND SOUL STUDY OUTCOME EVENT - MORBIDITY REVIEW FORM : DISCHARGE DATE: RECORDS FROM: Hospitalization ER Please check all that may apply: Myocardial Infarction Pages 2, 3,

More information

Stroke/TIA. Tom Bedwell

Stroke/TIA. Tom Bedwell Stroke/TIA Tom Bedwell tab1g11@soton.ac.uk The Plan Definitions Anatomy Recap Aetiology Pathology Syndromes Brocas / Wernickes Investigations Management Prevention & Prognosis TIAs Key Definitions Transient

More information

NEURO IMAGING 2. Dr. Said Huwaijah Chairman of radiology Dep, Damascus Univercity

NEURO IMAGING 2. Dr. Said Huwaijah Chairman of radiology Dep, Damascus Univercity NEURO IMAGING 2 Dr. Said Huwaijah Chairman of radiology Dep, Damascus Univercity I. EPIDURAL HEMATOMA (EDH) LOCATION Seventy to seventy-five percent occur in temporoparietal region. CAUSE Most likely caused

More information

CT and MR Imaging in Young Stroke Patients

CT and MR Imaging in Young Stroke Patients CT and MR Imaging in Young Stroke Patients Ashfaq A. Razzaq,Behram A. Khan,Shahid Baig ( Department of Neurology, Aga Khan University Hospital, Karachi. ) Abstract Pages with reference to book, From 66

More information

Cryptogenic Strokes: Evaluation and Management

Cryptogenic Strokes: Evaluation and Management Cryptogenic Strokes: Evaluation and Management 77 yo man with hypertension and hyperlipidemia developed onset of left hemiparesis and right gaze preference, last seen normal at 10:00 AM Brought to ZSFG

More information

Case # 1. Page: 8. DUKE: Adams

Case # 1. Page: 8. DUKE: Adams Case # 1 Page: 8 1. The cardiac output in this patient is reduced because of: O a) tamponade physiology O b) restrictive physiology O c) coronary artery disease O d) left bundle branch block Page: 8 1.

More information

Stroke - Intracranial hemorrhage. Dr. Amitesh Aggarwal Associate Professor Department of Medicine

Stroke - Intracranial hemorrhage. Dr. Amitesh Aggarwal Associate Professor Department of Medicine Stroke - Intracranial hemorrhage Dr. Amitesh Aggarwal Associate Professor Department of Medicine Etiology and pathogenesis ICH accounts for ~10% of all strokes 30 day mortality - 35 45% Incidence rates

More information

Identifying Cerebrovascular Disorders. Wengui Yu, MD, PhD Department of Neurology, University of California, Irvine

Identifying Cerebrovascular Disorders. Wengui Yu, MD, PhD Department of Neurology, University of California, Irvine Identifying Cerebrovascular Disorders Wengui Yu, MD, PhD Department of Neurology, University of California, Irvine Objectives Review different types of cerebrovascular disorders. Briefly discuss etiology,

More information

WHI Form Report of Cardiovascular Outcome Ver (For items 1-11, each question specifies mark one or mark all that apply.

WHI Form Report of Cardiovascular Outcome Ver (For items 1-11, each question specifies mark one or mark all that apply. WHI Form - Report of Cardiovascular Outcome Ver. 6. COMMENTS To be completed by Physician Adjudicator Date Completed: - - (M/D/Y) Adjudicator Code: OMB# 095-044 Exp: 4/06 -Affix label here- Clinical Center/ID:

More information

True cryptogenic stroke

True cryptogenic stroke True cryptogenic stroke Arne Lindgren, MD, PhD Dept of Clinical Sciences Lund, Neurology, Lund University Dept of Neurology and Rehabilitation Medicine Skåne University Hospital Lund, Sweden Disclosures

More information

Blood Supply. Allen Chung, class of 2013

Blood Supply. Allen Chung, class of 2013 Blood Supply Allen Chung, class of 2013 Objectives Understand the importance of the cerebral circulation. Understand stroke and the types of vascular problems that cause it. Understand ischemic penumbra

More information

Echocardiography after stroke - where to look

Echocardiography after stroke - where to look Echocardiography after stroke - where to look Vuyisile T. Nkomo, MD,MPH, FACC, FASE Joint Cardiac Imaging Society of South Africa/Mayo Clinic Echocardiography Workshop 2017 2016 MFMER slide-1 Disclosures

More information

Key Clinical Concepts

Key Clinical Concepts Cerebrovascular Review and General Vascular Syndromes, Including Those That Impact Dizziness Key Clinical Concepts Basic Review of Cerebrovascular Circulation Circulation to the brain is divided into anterior

More information

Cardiovascular Disease

Cardiovascular Disease Cardiovascular Disease Certification Examination Blueprints Blueprint for the Full-Day, Multiple-Choice Questions Component of the Exam: Purpose of the exam The exam is designed to evaluate the knowledge,

More information

Index. Note: Page numbers of article titles are in boldface type.

Index. Note: Page numbers of article titles are in boldface type. Index Note: Page numbers of article titles are in boldface type. A Acute coronary syndrome(s), anticoagulant therapy in, 706, 707 antiplatelet therapy in, 702 ß-blockers in, 703 cardiac biomarkers in,

More information

Cerebro-vascular stroke

Cerebro-vascular stroke Cerebro-vascular stroke CT Terminology Hypodense lesion = lesion of lower density than the normal brain tissue Hyperdense lesion = lesion of higher density than normal brain tissue Isodense lesion = lesion

More information

When Should I Order a Stress Test or an Echocardiogram

When Should I Order a Stress Test or an Echocardiogram When Should I Order a Stress Test or an Echocardiogram Updates in Cardiology 2015 March 7, 2015 Donald L. Lappé, MD, FAHA, FACC Chairman, Cardiovascular Department Medical Director, Intermountain Cardiovascular

More information

Ischemic heart disease

Ischemic heart disease Ischemic heart disease Introduction In > 90% of cases: the cause is: reduced coronary blood flow secondary to: obstructive atherosclerotic vascular disease so most of the time it is called: coronary artery

More information

INDEX NEUROLOGIC MANIFESTATIONS OF SYSTEMIC DISEASE. Note: Page numbers of article titles are in boldface type.

INDEX NEUROLOGIC MANIFESTATIONS OF SYSTEMIC DISEASE. Note: Page numbers of article titles are in boldface type. NEUROLOGIC MANIFESTATIONS OF SYSTEMIC DISEASE INDEX Note: Page numbers of article titles are in boldface type. Abuse, drug, CNS vasculopathy and, 130 131 Acromegaly, 46 48 causes of, 46 47 clinical presentation

More information

Pediatrics. Arrhythmias in Children: Bradycardia and Tachycardia Diagnosis and Treatment. Overview

Pediatrics. Arrhythmias in Children: Bradycardia and Tachycardia Diagnosis and Treatment. Overview Pediatrics Arrhythmias in Children: Bradycardia and Tachycardia Diagnosis and Treatment See online here The most common form of cardiac arrhythmia in children is sinus tachycardia which can be caused by

More information

PROSTHETIC VALVE BOARD REVIEW

PROSTHETIC VALVE BOARD REVIEW PROSTHETIC VALVE BOARD REVIEW The correct answer D This two chamber view shows a porcine mitral prosthesis with the typical appearance of the struts although the leaflets are not well seen. The valve

More information

TSDA Boot Camp September 13-16, Introduction to Aortic Valve Surgery. George L. Hicks, Jr., MD

TSDA Boot Camp September 13-16, Introduction to Aortic Valve Surgery. George L. Hicks, Jr., MD TSDA Boot Camp September 13-16, 2018 Introduction to Aortic Valve Surgery George L. Hicks, Jr., MD Aortic Valve Pathology and Treatment Valvular Aortic Stenosis in Adults Average Course (Post mortem data)

More information

Cryptogenic Stroke: Finding Light in the Darkness

Cryptogenic Stroke: Finding Light in the Darkness Cryptogenic Stroke: Finding Light in the Darkness Scott E. Kasner, MD Professor of Neurology Director, Comprehensive Stroke Center Disclosures WL Gore PI for Gore REDUCE Trial Medtronic DSMB for CRYSTAL

More information

Speakers. 2015, American Heart Association 1

Speakers. 2015, American Heart Association 1 Speakers Lee Schwamm, MD, FAHA Executive Vice Chairman of Neurology, Massachusetts General Hospital Director, Stroke Service and Medical Director, MGH TeleHealth, Massachusetts General Hospital Director,

More information

Common Codes for ICD-10

Common Codes for ICD-10 Common Codes for ICD-10 Specialty: Cardiology *Always utilize more specific codes first. ABNORMALITIES OF HEART RHYTHM ICD-9-CM Codes: 427.81, 427.89, 785.0, 785.1, 785.3 R00.0 Tachycardia, unspecified

More information

Permanent foramen ovale: when to close?

Permanent foramen ovale: when to close? Permanent foramen ovale: when to close? Pierre Amarenco INSERM U-698 and Denis Diderot University - Paris VII Department of Neurology and Stroke Center Bichat hospital, Paris, France PFO - Pathology TEE

More information

Hemodynamic Disorders, Thrombosis, and Shock. Richard A. McPherson, M.D.

Hemodynamic Disorders, Thrombosis, and Shock. Richard A. McPherson, M.D. Hemodynamic Disorders, Thrombosis, and Shock Richard A. McPherson, M.D. Edema The accumulation of abnormal amounts of fluid in intercellular spaces of body cavities. Inflammation and release of mediators

More information

Images in Cardiovascular Medicine

Images in Cardiovascular Medicine Images in Cardiovascular Medicine Numerous Small Vegetations Revealing Libman-Sacks Endocarditis in Catastrophic Antiphospholipid Syndrome Hideo Yamamoto, MD; Tamaki Iwade, MD; Ryuji Nakano, MD; Masahiro

More information

Arrhythmia 341. Ahmad Hersi Professor of Cardiology KSU

Arrhythmia 341. Ahmad Hersi Professor of Cardiology KSU Arrhythmia 341 Ahmad Hersi Professor of Cardiology KSU Objectives Epidemiology and Mechanisms of AF Evaluation of AF patients Classification of AF Treatment and Risk stratification of AF Identify other

More information

What Are We Going to Do? Fourth Year Meds Clinical Neuroanatomy. Hydrocephalus and Effects of Interruption of CSF Flow. Tube Blockage Doctrine

What Are We Going to Do? Fourth Year Meds Clinical Neuroanatomy. Hydrocephalus and Effects of Interruption of CSF Flow. Tube Blockage Doctrine Fourth Year Meds Clinical Neuroanatomy Ventricles, CSF, Brain Swelling etc. David A. Ramsay, Neuropathologist, LHSC What Are We Going to Do? Hydrocephalus and some effects of the interruption of CSF flow

More information

CEREBROVASCULAR DISEASES. By: Shifaa AlQa qa

CEREBROVASCULAR DISEASES. By: Shifaa AlQa qa CEREBROVASCULAR DISEASES By: Shifaa AlQa qa Cerebrovascular diseases Brain disorders caused by pathologic processes involving blood vessels 3 pathogenic mechanisms (1) thrombotic occlusion, (2) embolic

More information

CARDIOVASCULAR DISEASE Maintenance of Certification (MOC) Examination Blueprint

CARDIOVASCULAR DISEASE Maintenance of Certification (MOC) Examination Blueprint CARDIOVASCULAR DISEASE Maintenance of Certification (MOC) Examination Blueprint ABIM invites diplomates to help develop the Cardiovascular Disease MOC exam blueprint Based on feedback from physicians that

More information

Is Stroke a Paradoxical Embolism in Patients with Patent Foramen Ovale?

Is Stroke a Paradoxical Embolism in Patients with Patent Foramen Ovale? ORIGINAL ARTICLE Is Stroke a Paradoxical Embolism in Patients with Patent Foramen Ovale? Masahiro YASAKA, Ryoichi OTSUBO, Hiroshi OE and Kazuo MINEMATSU Abstract Objective Purpose was to assess the stroke

More information

7. Echocardiography Appropriate Use Criteria (by Indication)

7. Echocardiography Appropriate Use Criteria (by Indication) Criteria for Echocardiography 1133 7. Echocardiography Criteria (by ) Table 1. TTE for General Evaluation of Cardiac Structure and Function Suspected Cardiac Etiology General With TTE 1. Symptoms or conditions

More information

Emergency Department Stroke Registry Indicator Specifications 2018 Report Year (07/01/2017 to 06/30/2018 Discharge Dates)

Emergency Department Stroke Registry Indicator Specifications 2018 Report Year (07/01/2017 to 06/30/2018 Discharge Dates) 2018 Report Year (07/01/2017 to 06/30/2018 Discharge Dates) Summary of Changes I62.9 added to hemorrhagic stroke ICD-10-CM diagnosis code list (table 3) Measure Description Methodology Rationale Measurement

More information

Supplementary Appendix

Supplementary Appendix Supplementary Appendix This appendix has been provided by the authors to give readers additional information about their work. Supplement to: Kang D-H, Kim Y-J, Kim S-H, et al. Early surgery versus conventional

More information

Disclosures/Conflicts

Disclosures/Conflicts 42nd Annual Recent Advances in Neurology Thursday, February 12, 2009 Cerebral Vasculitis (Primary CNS Vasculitis) Disclosures/Conflicts None J. Donald Easton Department of Clinical Neurosciences Alpert

More information

Case 47 Clinical Presentation

Case 47 Clinical Presentation 93 Case 47 C Clinical Presentation 45-year-old man presents with chest pain and new onset of a murmur. Echocardiography shows severe aortic insufficiency. 94 RadCases Cardiac Imaging Imaging Findings C

More information

Atrial Fibrillation and the NOAC s. John Raymond MS, PA-C, MHP February 10, 2018

Atrial Fibrillation and the NOAC s. John Raymond MS, PA-C, MHP February 10, 2018 Atrial Fibrillation and the NOAC s John Raymond MS, PA-C, MHP February 10, 2018 Pathogenesis EPIDEMIOLOGY Arrhythmia-related hospitalisations in the US Ventricular fibrillation 2% Atrial fibrillation 34%

More information

Cardiology/Cardiothoracic

Cardiology/Cardiothoracic Cardiology/Cardiothoracic ICD-9-CM to ICD-10-CM Code Mapper 800-334-5724 www.contexomedia.com 2013 ICD-9-CM 272.0 Pure hypercholesterolemia 272.2 Mixed hyperlipidemia 272.4 Other and hyperlipidemia 278.00

More information

Supplementary material 1. Definitions of study endpoints (extracted from the Endpoint Validation Committee Charter) 1.

Supplementary material 1. Definitions of study endpoints (extracted from the Endpoint Validation Committee Charter) 1. Rationale, design, and baseline characteristics of the SIGNIFY trial: a randomized, double-blind, placebo-controlled trial of ivabradine in patients with stable coronary artery disease without clinical

More information

North Oaks Trauma Symposium Friday, November 3, 2017

North Oaks Trauma Symposium Friday, November 3, 2017 Traumatic Intracranial Hemorrhage Aaron C. Sigler, DO, MS Neurosurgery Tulane Neurosciences None Disclosures Overview Anatomy Epidural hematoma Subdural hematoma Cerebral contusions Outline Traumatic ICH

More information

TRANSCRANIAL DOPPLER ULTRASOUND INTRODUCTION TO TCD INTERPRETATION

TRANSCRANIAL DOPPLER ULTRASOUND INTRODUCTION TO TCD INTERPRETATION TRANSCRANIAL DOPPLER ULTRASOUND INTRODUCTION TO TCD INTERPRETATION ---Rune Aaslid First TCD Publication 1982 WHAT IS TCD? Uses 2 MHz pulsed Doppler ultrasound Passes through cranial windows Provides information

More information

Cardiovascular Disorders. Heart Disorders. Diagnostic Tests for CV Function. Bio 375. Pathophysiology

Cardiovascular Disorders. Heart Disorders. Diagnostic Tests for CV Function. Bio 375. Pathophysiology Cardiovascular Disorders Bio 375 Pathophysiology Heart Disorders Heart disease is ranked as a major cause of death in the U.S. Common heart diseases include: Congenital heart defects Hypertensive heart

More information

ASE 2011 Appropriate Use Criteria for Echocardiography

ASE 2011 Appropriate Use Criteria for Echocardiography ASE 2011 Appropriate Use Criteria for Echocardiography Table 1. TTE for General Evaluation of Cardiac Structure and Function 1 2 Suspected Cardiac Etiology General With TTE Symptoms or conditions potentially

More information

Cerebrovascular diseases-2

Cerebrovascular diseases-2 Cerebrovascular diseases-2 Primary angiitis of CNS - Other causes of infarction i. Hypercoagulable states ii. Drug-abuse such as amphetamine, heroin and cocain Note - The venous side of the circulation

More information

Cardiovascular Disorders Lecture 3 Coronar Artery Diseases

Cardiovascular Disorders Lecture 3 Coronar Artery Diseases Cardiovascular Disorders Lecture 3 Coronar Artery Diseases By Prof. El Sayed Abdel Fattah Eid Lecturer of Internal Medicine Delta University Coronary Heart Diseases It is the leading cause of death in

More information

Radiology of the respiratory/cardiac diseases (part 2)

Radiology of the respiratory/cardiac diseases (part 2) Cardiology Cycle - Lecture 6 436 Teams Radiology of the respiratory/cardiac diseases (part 2) Objectives Done By Team Leaders: Khalid Alshehri Hanin Bashaikh Team Members: Leena Alwakeel Aroob Alhuthail

More information

Cardiac Radiology In-Training Test Questions for Diagnostic Radiology Residents

Cardiac Radiology In-Training Test Questions for Diagnostic Radiology Residents Cardiac Radiology In-Training Test Questions for Diagnostic Radiology Residents March, 2013 Sponsored by: Commission on Education Committee on Residency Training in Diagnostic Radiology 2013 by American

More information

THE FRAMINGHAM STUDY Protocol for data set vr_soe_2009_m_0522 CRITERIA FOR EVENTS. 1. Cardiovascular Disease

THE FRAMINGHAM STUDY Protocol for data set vr_soe_2009_m_0522 CRITERIA FOR EVENTS. 1. Cardiovascular Disease THE FRAMINGHAM STUDY Protocol for data set vr_soe_2009_m_0522 CRITERIA FOR EVENTS 1. Cardiovascular Disease Cardiovascular disease is considered to have developed if there was a definite manifestation

More information

DIAGNOSTIC CRITERIA OF AMI/ACS

DIAGNOSTIC CRITERIA OF AMI/ACS DIAGNOSTIC CRITERIA OF AMI/ACS Diagnostic criteria are used to validate clinical diagnoses. Those used in epidemiological studies are here below reported. 1. MONICA - Monitoring trends and determinants

More information

ST - segment Elevation Myocardial Infarction complicating an atypical Kawasaki disease

ST - segment Elevation Myocardial Infarction complicating an atypical Kawasaki disease ST - segment Elevation Myocardial Infarction complicating an atypical Kawasaki disease Raluca PRISECARU, Marc VINCENT, Steven VERCAUTEREN Brussels Heart Center, Brussels, Belgium Disclosure None Clinical

More information

The Epidemiology of Stroke and Vascular Risk Factors in Cognitive Aging

The Epidemiology of Stroke and Vascular Risk Factors in Cognitive Aging The Epidemiology of Stroke and Vascular Risk Factors in Cognitive Aging REBECCA F. GOTTESMAN, MD PHD ASSOCIATE PROFESSOR OF NEUROLOGY AND EPIDEMIOLOGY JOHNS HOPKINS UNIVERSITY OCTOBER 20, 2014 Outline

More information

Cardiovascular Nursing Practice: A Comprehensive Resource Manual and Study Guide for Clinical Nurses 2 nd Edition

Cardiovascular Nursing Practice: A Comprehensive Resource Manual and Study Guide for Clinical Nurses 2 nd Edition Cardiovascular Nursing Practice: A Comprehensive Resource Manual and Study Guide for Clinical Nurses 2 nd Edition Table of Contents Volume 1 Chapter 1: Cardiovascular Anatomy and Physiology Basic Cardiac

More information

Chest Pain. Dr. Amitesh Aggarwal. Department of Medicine

Chest Pain. Dr. Amitesh Aggarwal. Department of Medicine Chest Pain Dr. Amitesh Aggarwal Department of Medicine BACKGROUND Approx 5% of all ED visits 15 % - AMI 25-30 % - Unstable angina 50-55 % - Other conditions Atypical presentations common 2% of patients

More information

Conflict Disclosures. Vermont Cardiac Network. Outline. Series Learning Objectives 4/27/2016. Scott E. Friedman April 28, 2016

Conflict Disclosures. Vermont Cardiac Network. Outline. Series Learning Objectives 4/27/2016. Scott E. Friedman April 28, 2016 Conflict Disclosures Vermont Cardiac Network The Speaker has reported no significant financial relationship with any companies whose product may be germane to the content of their presentations or who

More information

Hematologic Disorders. Assistant professor of anesthesia

Hematologic Disorders. Assistant professor of anesthesia Preoperative Evaluation Hematologic Disorders Dr M.Razavi Assistant professor of anesthesia Anemia Evaluation needs to consider the extent and type of surgery, the anticipated blood loss, and the patient's

More information

DISCLOSURE. Echocardiography in Systemic Diseases: Questions. Relevant Financial Relationship(s) None. Off Label Usage None 5/7/2018

DISCLOSURE. Echocardiography in Systemic Diseases: Questions. Relevant Financial Relationship(s) None. Off Label Usage None 5/7/2018 Echocardiography in Systemic Diseases: Questions Sunil Mankad, MD, FACC, FCCP, FASE Associate Professor of Medicine Mayo Clinic College of Medicine Director, Transesophageal Echocardiography Associate

More information

CMS Limitations Guide - Cardiovascular Services

CMS Limitations Guide - Cardiovascular Services CMS Limitations Guide - Cardiovascular Services Starting October 1, 2015, CMS will update their existing medical necessity limitations on tests and procedures to correspond to ICD-10 codes. This limitations

More information

Moyamoya Disease A Vasculopathy and an Uncommon Cause of Recurrent Cerebrovascular Accidents

Moyamoya Disease A Vasculopathy and an Uncommon Cause of Recurrent Cerebrovascular Accidents Moyamoya Disease A Vasculopathy and an Uncommon Cause of Recurrent Cerebrovascular Accidents Yasmin S. Hamirani, Md 1 *, Mohammad Valikhani, Md 2, Allison Sweney, Ms Iii 2, Hafsa Khan, Md 2, Mohammad Pathan,

More information

The production of murmurs is due to 3 main factors:

The production of murmurs is due to 3 main factors: Heart murmurs The production of murmurs is due to 3 main factors: high blood flow rate through normal or abnormal orifices forward flow through a narrowed or irregular orifice into a dilated vessel or

More information

Alan Barber. Professor of Clinical Neurology University of Auckland

Alan Barber. Professor of Clinical Neurology University of Auckland Alan Barber Professor of Clinical Neurology University of Auckland Presented with L numbness & slurred speech 2 episodes; 10 mins & 2 hrs Hypertension Type II DM Examination P 80/min reg, BP 160/95, normal

More information

Seek and Ye Shall Find: Surprising Findings When Using the ILR-LINQ

Seek and Ye Shall Find: Surprising Findings When Using the ILR-LINQ Seek and Ye Shall Find: Surprising Findings When Using the ILR-LINQ Suneet Mittal, MD, FACC, FHRS Director, Electrophysiology Laboratory Valley Health System www.arrhythmia.org; @drsuneet October 31, 2015

More information

THROMBOSIS. Dr. Nisreen Abu Shahin Assistant Professor of Pathology Pathology Department University of Jordan

THROMBOSIS. Dr. Nisreen Abu Shahin Assistant Professor of Pathology Pathology Department University of Jordan THROMBOSIS Dr. Nisreen Abu Shahin Assistant Professor of Pathology Pathology Department University of Jordan NORMAL BLOOD VESSEL HISTOLOGY THROMBOSIS Pathogenesis (called Virchow's triad): 1. Endothelial*

More information

MEET 2007: Evaluation and treatment of the stroke and TIA patient for the non-neurointerventionist. neurointerventionist

MEET 2007: Evaluation and treatment of the stroke and TIA patient for the non-neurointerventionist. neurointerventionist MEET 2007: Evaluation and treatment of the stroke and TIA patient for the non-neurointerventionist neurointerventionist Steve Ramee, MD Ochsner Medical Center New Orleans DISCLOSURE Nothing Nothing to

More information

Alan Barber. Professor of Clinical Neurology University of Auckland

Alan Barber. Professor of Clinical Neurology University of Auckland Alan Barber Professor of Clinical Neurology University of Auckland Presented with Non-fluent dysphasia R facial weakness Background Ischaemic heart disease Hypertension Hyperlipidemia L MCA branch

More information

Aerobic Exercise Screening Stratification Tool

Aerobic Exercise Screening Stratification Tool Aerobic Screening Stratification Tool Disclaimer: The Aerobics Screening Stratification Tool is a working document currently used within the Stroke Rehabilitation Service of St. Joseph s Care Group- Thunder

More information

Supplement Table 1. Definitions for Causes of Death

Supplement Table 1. Definitions for Causes of Death Supplement Table 1. Definitions for Causes of Death 3. Cause of Death: To record the primary cause of death. Record only one answer. Classify cause of death as one of the following: 3.1 Cardiac: Death

More information

Pathophysiology. Tutorial 3 Hemodynamic Disorders

Pathophysiology. Tutorial 3 Hemodynamic Disorders Pathophysiology Tutorial 3 Hemodynamic Disorders ILOs Recall different causes of thrombosis. Explain different types of embolism and their predisposing factors. Differentiate between hemorrhage types.

More information

Ve V rmont rmon Card Car iac d Netw Ne ork tw Scott E. Friedman April 28, 2016

Ve V rmont rmon Card Car iac d Netw Ne ork tw Scott E. Friedman April 28, 2016 Vermont Cardiac Network Scott E. Friedman April 28, 2016 Conflict Disclosures Th S k h d i ifi fi i l l i hi ih The Speaker has reported no significant financial relationship with any companies whose product

More information